Page last updated: 2024-08-21

cyclopentane and Adenocarcinoma, Mucinous

cyclopentane has been researched along with Adenocarcinoma, Mucinous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardelli, A; Bertotti, A; Di Nicolantonio, F; Grillone, K; Isella, C; Medico, E; Migliardi, G; Petti, C; Picco, G; Rossi, T; Sapino, A; Sarotto, I; Sassi, F; Trusolino, L1

Other Studies

1 other study(ies) available for cyclopentane and Adenocarcinoma, Mucinous

ArticleYear
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.
    Journal of the National Cancer Institute, 2017, Volume: 109, Issue:2

    Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Apoptosis; Cadherins; CDX2 Transcription Factor; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colorectal Neoplasms; Cyclopentanes; Disease-Free Survival; DNA Replication; Drug Resistance, Neoplasm; Female; Homeodomain Proteins; Humans; Keratin-20; Mice; NEDD8 Protein; Neoplasm Grading; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction; Transcriptome; Ubiquitins

2017